 RCT vs placebo, ﬁve vs comparative VAD
(hydroxyrutosides and MPFF), and six observational
studies, with a total of 10,246 patients (Table IX).

20

Gloviczki et al

Journal of Vascular Surgery: Venous and Lymphatic Disorders
January 2024

Table VIII. Micronized puriﬁed ﬂavonoid fraction (MPFF) therapy